Skip to main content

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.


  • Default content image

    MJFF Awardee Announces Collaborative Agreement With GlaxoSmithKline

    Today, MJFF awardee ProteoTech, Inc., a privately held biotechnology company, announced a funding agreement with GlaxoSmithKline (China) R&D Company Limited (GSK) to collaborate on ProteoTech’s…
    Learn more

  • Default content image

    Fox Trial Finder: A Sneak Peek at 2012

    Thank you for helping make Fox Trial Finder’s first months a success. Over 1,750 volunteers have completed profiles on the site since we launched in July. Many of you have provided valuable feedback,
    Learn more

  • Default content image

    Pioneering Partnership with MJFF Drives New Parkinson's Treatment Toward Pharmacy Shelves

    With MJFF funding, Jeff Conn, PhD, at Vanderbilt University has accelerated a promising new PD treatment toward the clinic. Instead of targeting the dopamine system, his approach focuses on the…
    Learn more

  • Default content image

    Complete Your Fox Trial Finder Profile to Help Speed the Cure

    As a Fox Trial Finder volunteer, the more information you complete in your profile, the better your potential trial matches will be!
    Learn more

  • Default content image

    MJFF Awardee Dr. James Greene Publishes on Gastrointestinal Problems in PD

    MJFF continues to work to address research focused on the unmet needs of people living Parkinson’s disease (PD) today. 
    Learn more

  • Default content image

    New Study Protocol incorporating following subjects with SWEDD now posted

    An updated protocol has been posted to the PPMI site. This is the 3rd amendment to the protocol and incorporates a third cohort into the PPMI study.
    Learn more

Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.